Oncology
1 Results
- Oncology
Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical Recurrence
UrologyVol. 108p129–134Published online: July 19, 2017- Stephanie L. Skove
- Lauren E. Howard
- William J. Aronson
- Martha K. Terris
- Christopher J. Kane
- Christopher L. Amling
- and others
Cited in Scopus: 15To evaluate the association between the prostate-specific antigen (PSA) nadir level and the time to nadir (TTN) with biochemical recurrence (BCR) risk after radical prostatectomy (RP) in the Shared Equal-Access Research Cancer Hospital (SEARCH) database.